Thailand Board Of Investment Hosts Thai Pavilion At BIO 2016

Share Article

Thailand Sends Delegation to BIO International Conference in San Francisco

News Image
Thailand has one of the most robust biotech industries in the ASEAN market, which is underpinned by incentives and our Government’s unwavering support of the Life Sciences sector.

Thailand’s Board of Investment’s New York office, announces the participation of a Thai delegation at BIO 2016 in San Francisco. Located at booth number 7301, representatives from the Thai Government, research organizations, and the private sector will be available to answer questions and discuss the Thai biotechnology and life sciences sector.

Deputy Secretary General of the Thailand Board of Investment, Ms. Ajarin Pattanapanchai, will be representing the Thai Government at the BIO Convention along with colleagues from the Board of Investment’s U.S. offices. Also attending will be The Thailand Center of Excellence for Life Sciences (TCELS), represented by Dr. Nares Damrongchai, the CEO of TCELS. Dr. Songpon Deechongkit, the Managing Director of Siam Bioscience Co, Ltd. will be on hand to brief companies on the assets and life sciences ecosystem in Thailand.

Some of the categories of Thai companies and organizations in attendance at the Thailand Pavilion include:

  • Biopharmaceuticals
  • National Biopharmaceutical Facility
  • Austria Nova Thailand
  • Siam Bio Science Co.
  • ACLIRES Bangkok
  • Greater Pharma
  • Medical Services
  • Thailand Center of Excellence for Life Sciences (TCELS)
  • Natural Products & Cosmetics
  • Cosmetics and Natural Products Research Center
  • Wanithai
  • Medical Devices
  • National Nanotechnology Center
  • Silicon Craft Technology Co., Ltd
  • Supporting Agencies
  • Thailand Board of Investment
  • Thailand Center of Excellence for Life Sciences (TCELS)

Thailand has one of the most robust biotech industries in the ASEAN market, which is underpinned by incentives and our Government’s unwavering support of the Life Sciences sector. Two of our areas of specialization are in agricultural biotech and public health. Thailand boasts over 200 biotech firms with a combined market value of over $2 billion and has led on ground-breaking research ranging from the nutritional enhancement of core crops, to diagnosing viruses in shrimp, and researching mosquito borne illnesses.

There are 11 Thai companies and organizations participating at BIO. One of these is Wanithai, which is conducting R&D with crocodile blood for use as a food supplement in the treatment of Anemia, Asthma, Diabetes Mellitus, and Cancer.

Also in attendance is ACLIRES Bangkok, an independent phase I-IV Clinical Research Organization and Siam Bio Science Co, which specializes in oncology, autoimmune diseases, hematology and metabolic disorders.

About BOI
The Thailand Board of Investment (BOI) is the investment promotion agency for Thailand that facilitates foreign direct investment. BOI’s services are free of charge and customized to help business succeed in Thailand. For more information, please visit http://www.boi.go.th and http://www.thinkasiainvestthailand.com/web/indexen.php.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Margolis
Conway, Inc.
+1 917 331 4855
Email >
@Thailand_Invest
Follow >
Thailand Board of Investment North America
Like >
Thailand Board of Investment North America

Visit website